New diabetes drug recall over cancer-causing ingredient

One lot of another brand of Type 2 diabetes medicine metformin, Riomet ER, has been recalled after laboratory tests revealed the drug had too much of carcinogen NDMA.

Sun Pharmaceuticals Industries, also called Sun Pharma, pulled lot No. AB06381 of Riomet, 500 mg tablets of metformin hydrochloride for extended-release oral suspension. The expiration date is 10/2021. Sun’s FDA-posted recall notice says this went to wholesalers nationwide, but didn’t state to what retailers those wholesalers sold their product.

riomet recalled.jpg
The Riomet ER diabetes medicine recalled by Sun Pharmaceutical Industries aka Sun Pharma FDA

This is the ninth brand of metformin recalled for NDMA (N-Nitrosodimethylamine) since May, the full list of which can be found on the FDA’s website.

Those with questions on this recall can call Sun Pharma at 800-818-4555, Monday through Friday, 8 a.m. to 5 p.m., Eastern time.

Since 1989, David J. Neal’s domain at the Miami Herald has expanded to include writing about Panthers (NHL and FIU), Dolphins, old school animation, food safety, fraud, naughty lawyers, bad doctors and all manner of breaking news. He drinks coladas whole. He does not work Indianapolis 500 Race Day.

Source Article

Next Post

Fresenius Medical Care North America Celebrates Nephrology Nurses Week, Honoring Nurses' Selfless Commitment During Pandemic

Sat Sep 26 , 2020
Company Continues Support for The American Nephrology Nurses Association (ANNA) to Help Advance Practice of Nephrology Nursing Through Engagement and Education WALTHAM, Mass., Sept. 14, 2020 /PRNewswire/ — Fresenius Medical Care North America (FMCNA), the nation’s leading renal care company, is celebrating Nephrology Nurses Week in partnership with the American […]